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Objective: Diffuse idiopathic skeletal hyperostosis (DISH) has been associated with an increased risk of verte-
bral fracture. To date, no studies have investigated the relationship between DISH and bone microstructure
assessed by the trabecular bone score (TBS).
Methods: Cross-sectional study, nested in a prospective population-based cohort. All men (968)
aged50 years were included. Clinical covariates, DISH, TBS, serum bone turnover markers and bone mineral
density (BMD) were analyzed.
Results: Mean age of participants was 65 § 9 years. 207 (21.6%) had DISH. DISH subjects were older, had
higher body mass index (BMI) and abdominal perimeter, lower glomerular filtration rate (GFR), and higher
prevalence of metabolic syndrome (MetS) than non-DISH (NDISH) subjects. Bone mineral density at the lum-
bar spine (LS-BMD) was significantly higher in the DISH group. TBS values were 1.317 [1.3031.331] for
DISH and 1.334 [1.3271.341] for NDISH subjects, after adjusting by age, BMI, abdominal perimeter, arterial
hypertension, diabetes mellitus, MetS, GFR, serum alkaline phosphatase (ALP), LS and femoral neck BMD
(p = 0.03). Serum ALP levels were higher in DISH subjects, showing an inverse correlation with TBS that
remained significant after adjusting by age and BMI.
Conclusions: TBS values were significantly lower in men with DISH irrespective of age, BMI and BMD, suggest-
ing that the presence of DISH might be related to a worse trabecular microstructure.
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Diffuse idiopathic skeletal hyperostosis (DISH) is a non-inflamma-
tory rheumatic disorder characterized by ossification of ligaments,
tendons and joint capsules, first described by Forestier and Rotes-
Querol in 1950 [1,2]. It can affect numerous locations, but the
involvement of the anterior vertebral ligament of the thoracic spine
is the most characteristic manifestation of the disease [3,4]. DISH is
more frequent in older men and its pathogenesis remains unknown,
although genetic, mechanical and metabolic factors, mainly abdomi-
nal obesity, have been involved [4,5]. Furthermore, growth factors,
bone morphogenetic proteins (BMP) or adipokines, have also been
implicated in DISH pathogenesis, since they would act on the fibro-
blasts, chondrocytes and collagen fibers of the entheses promoting
bone neoformation [6].DISH is usually an asymptomatic condition, although joint pain,
limited axial mobility, dysphagia, airway obstruction, as well as
increased susceptibility to vertebral fractures, have been reported
[79]. These fractures are often associated with neurological compli-
cations and higher mortality rate [10]. The role of bone mineral den-
sity (BMD) in the development of vertebral fractures in subjects with
DISH represents a matter of debate [11]. High BMD values have been
reported in these patients, both in the axial [12] and in the appendic-
ular skeleton [1315], which would paradoxically imply a lower risk
of fracture. In fact, it has been pointed out that the bone in DISH is
denser but at the same time more fragile [7]. However, some other
authors have questioned this observation, suggesting that high BMD
values measured by dual-energy x-ray absorptiometry (DXA) may be
overestimated, due to the effect of anterior vertebral ligament ossifi-
cation [11].
Nevertheless, there are other factors that can contribute to the
risk of fracture, independently of BMD, such as the rate of bone turn-
over, the degree of matrix mineralization, the geometry (dimensions,
cortical thickness) or the integrity of the trabecular structure, all
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[16,17].
Data on bone biomarkers in patients with DISH are scarce, and
increased levels of osteocalcin, secreted frizzled-related proteins and
sclerostin and decreased levels of dickkopf-related protein 1 (DKK-1)
have been reported [18,19].
Trabecular bone score (TBS) is an image technique developed to
indirectly evaluate the state of the trabecular microarchitecture
based on the information provided by the standard DXA [20]. It con-
sists of a texture parameter that evaluates pixel gray-level variations
in the projected lumbar spine DXA image. Thus, TBS may be consid-
ered as an overall index of bone quality and low values have been
associated with a worse bone structure and a higher risk of fracture
[20,21]. The usefulness of TBS in fracture risk assessment or for thera-
peutic recommendations in patients with osteoporosis has been
addressed in a recent Position Development Conference by The Inter-
national Society for Clinical Densitometry [22].
To our knowledge, TBS values in patients with DISH have not been
reported to date.
Based on these considerations, our aim has been to assess the TBS
values in a population-based cohort of men aged 50 years or older,
with and without DISH. Given the paucity of data, a second objective
has been to compare the serum levels of markers of bone formation
and bone resorption in DISH and non-DISH (NDISH) subjects.Patients and methods
Population and sample
The study population included all the men aged 50 years taking
part in a prospective population-based cohort, the Camargo Cohort,
whose full details have been previously published [23]. Briefly, the
Camargo Cohort was set up in 2006 to assess the prevalence and inci-
dence of bone metabolic diseases in postmenopausal women and
men aged 50 years, who attended two health care centers in Canta-
bria, Spain.
At baseline, patients were asked to complete a questionnaire on
bone metabolism and general diseases, current or past medication
use and risk factors for osteoporosis and fragility fractures. Moreover,
blood samples were collected and all the participants underwent lat-
eral thoracic and lumbar spine radiographs and a DXA exam. The
Camargo Cohort study was approved by the Clinical Research Ethics
Committee of Cantabria (Internal Code 2014.155). All participants
gave written informed consent.
Participants whose baseline assessment revealed the presence of
diseases or treatments known to affect bone metabolism, such as
osteoporosis, primary hyperparathyroidism, hyperthyroidism, serum
creatinine >1.7 mg/dl (151 mmol/L), or use of bisphosphonates,
estrogen, raloxifene, strontium ranelate, teriparatide, L-thyroxin,
anticonvulsants or glucocorticoids in the previous year, were
excluded. We also excluded patients with previous diagnosis of anky-
losing spondylitis or chronic liver disease.Clinical variables
Weight (in kg), height (in meters) and abdominal perimeter (in
cm) were obtained with the subjects wearing underwear and without
shoes. Body mass index (BMI) was measured in kg/m2, considering
obesity when BMI  30 kg/m2. Physical activity was categorized as
sedentary (sitting in a chair most of the time, short walks outside the
house), light (shopping, domestic work) or moderate-intense (daily
-or most days- exercise or intense work).
Smoking was defined as non-smokers or smokers (current smok-
ers and ex-smokers). Alcohol intake was defined as a daily consump-
tion greater than 20 g [24].Descargado para JosÃ© M. Olmos MartÃ-nez (miromj@humv.e
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morning after a requested 12-hour overnight fast. Serum concentra-
tions of calcium, phosphorus, albumin and total alkaline phosphatase
(ALP) were obtained by automated methods in an ADVIA 2400
Chemistry System autoanalyzer (Siemens, Germany). Serum concen-
trations of 25-hydroxyvitamin D (25-OHD), intact parathyroid hor-
mone (iPTH), amino-terminal pro-peptide of type 1 collagen (PINP)
and C-terminal telopeptide of type 1 collagen (CTX) were determined
by an automated method of electrochemiluminescence (Elecsys
2010, Roche Diagnostics, GmbH, Mannheim, Germany). The detection
limits for iPTH, P1NP and CTX were 6 pg/ml, 5 ng/ml and 0.01 ng/ml,
and the normality ranges were 1565 pg/ml, 1578 ng/ml and
0.0690.760 ng/ml, respectively. The glomerular filtration rate (GFR)
was estimated according to the CKD-EPI formula [25] and expressed
in ml/min/1.73 m2. Metabolic syndrome (MetS) was defined accord-
ing to the NCEP-ATPIII criteria [26].
BMD was measured by DXA, with a Hologic QDR-4500 device, at
the lumbar spine (LS-BMD), femoral neck (FN-BMD) and total hip
(TH-BMD). In-vivo precision was 0.41.5% at different locations, and
the results were expressed in gr/cm2. All measurements were made
by the same operator. The measurement of the TBS has been carried
out from the images of the DXA in LS (L1-L4) stored in the densitome-
ter memory, with the TBS iNsight software (TBS iNsight v2.1, Medi-
maps, Merignac, France) installed in the densitometer.
Two independent trained researchers, blinded to clinical data,
evaluated DISH and vertebral fractures. DISH was diagnosed accord-
ing to the Resnick and Niwayama criteria [27]: ossifications affecting
the anterior longitudinal vertebral ligament of at least 4 contiguous
vertebral bodies, a relative preservation of the intervertebral disk
space in the affected segment without signs of degenerative disk
changes, and the absence of apophyseal joint degeneration or sacroil-
iac inflammatory changes. The grade of vertebral fracture was
assessed by the semiquantitative method of Genant [28].
Statistical analysis
Quantitative variables were expressed as mean§standard devia-
tion (SD) or median [interquartile range], and categorical variables, in
percentage. Student-t-test, Mann-Whitney U test, median test and
ANOVA, were used to compare quantitative variables, and Pearsons
chi-squared test in the case of categorical variables. The relationships
between variables were initially analyzed through bivariate correla-
tions using Pearson or Spearman coefficients and then, univariable
linear regression models. The risk was expressed as prevalence odds
ratio (OR) with 95% confidence interval (95% CI). A general linear
regression model was built to assess the relationship between DISH
and TBS, including the covariates that showed significant differences
between DISH and NDISH groups. Bonferroni adjustment for multiple
testing was also carried out. A p-value <0.05 was considered statisti-
cally significant in all the analyses.
Results
A total of 1113 men aged 50 years were initially recruited. Of
them, 145 were excluded because of incomplete data or having dis-
eases or receiving treatments that affect bone metabolism. Thus, 968
participants (mean age, 65 § 9 years; range, 5092 years) were
finally included in the study, and 207 of them (21.6%) were diagnosed
with DISH.
DISH was associated with age (r = 0.202; p<0.0001) and BMI
(r = 0.111; p = 0.001). Thus, increasing prevalence of DISH was
observed in the elderly (15.6% in subjects<65 years vs. 29.2% in those
65 years; p < 0.0001) and in obese participants (17.3% in subjects
with BMI <30 vs. 28.8% in those with BMI 30; p<0.0001).
The main epidemiological characteristics of participants with and
without DISH are summarized in Table 1. DISH subjects were older,s) en IDIVAL, de ClinicalKey.es por Elsevier en abril 15, 2020.
ación. Copyright ©2020. Elsevier Inc. Todos los derechos reservados.
Table 1
Baseline clinical characteristics according to DISH status.
DISH (N = 207) NDISH (N = 761) P
Age, yrs. 67 (15) 62 (13) 0.0001
Body mass index, Kg/m2 29.9 (4.4) 28.7 (4.1) 0.0001
Abdominal perimeter, cm 105 (12.7) 101 (12) 0.0001
Obesity, n (%) 103 (49.7) 257 (33.7) 0.0001
Diabetes mellitus, n (%) 46 (22.2) 142 (18.6) 0.27
Arterial hypertension, n (%) 118 (57) 356 (46.8) 0.01
Dyslipidemia; n (%) 75 (36.2) 260 (34.1) 0.58
GFR,ml/min/1.73 m2 74.4 (21.8) 78 (23) 0.01
Metabolic syndrome; n (%) 99 (47.8) 238 (31.2) 0.0001
NDISH: Non-DISH. GFR: glomerular filtration rate.
Quantitative variables are expressed in median (interquartile range).
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prevalence of MetS than NDISH participants had. Besides, LS-BMD
was significantly higher in DISH subjects compared to the NDISH
group (Table 2), also with increased values in the oldest men:
1.044 vs. 0.988 g/cm2 in the group <65 years (p = 0.002), and
1.073 vs. 0.986 g/cm2 in those 65 years (p = 0.006).
TBS was inversely correlated to age (r = 0.179; p<0.0001) and
BMI (r = 0.467; p<0.0001). TBS median values were 1.328
[1.2221.405] in the DISH group vs. 1.352 [1.2551.433] in NDISH
subjects (p = 0.02) (Table 2). The presence of DISH was associated
with a lower TBS: 57.1% of the DISH subjects had a TBS below the
median of the whole sample (1.346), compared to 48.7% of the NDISH
subjects, with an unadjusted OR value of 1.40 (95% CI 1.031.92);
p = 0.03. After adjusting by age, BMI, abdominal perimeter, arterial
hypertension, diabetes mellitus, MetS, GFR, ALP, LS-BMD and FN-
BMD, TBS values were 1.317 [1.3031.331] and 1.334 [1.3271.341]
in DISH and NDISH groups, respectively (p = 0.03).
As the TBS shows better performance when BMI ranges from 15 to
35 kg/m2 [29], this issue was addressed by previously excluding sub-
jects with BMI >35 kg/m2 in the analysis. However, the results did
not virtually change when including these subjects (adjusted TBS
value of 1.325 [1.3141.336] in DISH vs 1.339 [1.3311.347] in
NDISH participants; p = 0.02)
Regarding bone biomarkers, subjects with DISH had higher serum
ALP levels than NDISH individuals (p = 0.049), while PINP and CTX
levels were similar in both groups. Serum ALP levels showed an
inverse correlation with TBS (r = 0.104; p = 0.001) that remainedTable 2
Bone metabolism parameters according to DISH status.
DISH (N = 207) NDISH (N = 761) P
Trabecular bone score (TBS),
unitless
1.328 (0.2) 1.352 (0.1) 0.02
Vertebral Fracture; n (%) 43 (20.7) 151 (19.8) 0.76
History of fracture> 40 years
old; n (%)
31 (15) 122 (16) 0.71
Albumin, g/dl 4.4 (0.3) 4.5 (0.5) 0.60
Calcium,mg/dl 9.5 (0.5) 9.5 (0.6) 0.65
Phosphate,mg/dl 3 (0.5) 3 (0.7) 0.39
iPTH, pg/ml 51.5 (24.6) 51.8 (24) 0.37
25(OH)D, ng/ml 22 (10.8) 22 (11) 0.42
Alkaline phosphatase, U/L 67 (23) 64 (22) 0.049
P1NP, ng/ml 35.5 (20.5) 34 (18.7) 0.32
CTX, ng/ml 0.2 (0.2) 0.2 (0.2) 0.50
LS BMD, g/cm2 1.05 (0.2) 0.98 (0.2) 0.0001
FN BMD, g/cm2 0.82 (0.2) 0.80 (0.1) 0.04
TH BMD, g/cm2 0.98 (0.1) 0.97 (0.1) 0.11
NDISH: Non-DISH. 25(OH)D: 25-hydroxyvitamin D; iPTH: intact parathyroid hor-
mone; P1NP: amino-terminal pro-peptide of type 1 collagen; CTX: C-terminal telo-
peptide of type 1 collagen. BMD: bone mineral density; LS; lumbar spine; FN:
femoral neck; TH: total hip.
Quantitative variables are expressed in median (interquartile range), with the
exception of total hip BMD, expressed as mean (standard deviation).
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Discussion
To our knowledge, this is the first study that assesses the TBS val-
ues in DISH subjects. We have shown that there is an inverse rela-
tionship between DISH and TBS, independently of age, BMI, BMD,
and other covariates. This finding might represent a biologically plau-
sible explanation, among others, of the propensity to vertebral frac-
tures independently of BMD found in patients with DISH.
Despite the great variability, the observed prevalence of DISH of
21.6% in men >50 years is in line with the data reported in studies
based on plain radiographs [30]. The clinical characteristics of DISH
patients observed in our study were also similar to those previously
published, specifically the higher average age and the higher preva-
lence of obesity [5]. Likewise, age has also been inversely associated
with TBS values [20], as observed in our study. Besides, obesity was
significantly more prevalent in our DISH group, and BMI and TBS
were inversely correlated. In this sense, there is a well-known rela-
tionship between obesity and DISH [4,5]. Serum adipokines with
effect on the regulation of bone metabolism (mainly leptin and adi-
ponectin) have been suggested as a potential pathophysiological link
[3133]. Furthermore, the metabolic environment of obesity (insulin
resistance and inflammation) may be associated with impaired bone
health in obese individuals [34]. With regard to TBS values in obese
subjects, a recent report has found that obesity was associated with a
low TBS in men, irrespective of BMD [35].
Concerning bone biomarkers in patients with DISH, there is not
yet a clearly established pattern. We have evaluated two serum
markers of bone formation, ALP and PINP, and a marker of bone
resorption, CTX. ALP values were significantly higher in the DISH
group and have shown an inverse correlation with TBS. In the same
line, increased ALP levels have been reported in DISH subjects [36].
Moreover, experimental studies seem to support this clinical obser-
vation, since an increase in ALP activity has been observed in liga-
ment cells cultures from patients with DISH, reflecting the
transformation of these cells into osteoblasts [37]. Some studies have
reported that the changes of the total ALP with age are essentially
due to the bone isoenzymes, and in fact, elevated ALP in postmeno-
pausal women has been reported to be mainly caused by high bone
turnover [38]. Serum osteocalcin has also been reported to be
increased in patients with DISH [18,39]. The higher levels of ALP and
the inverse correlation with TBS in DISH subjects might reflect the
sensitivity of trabecular bone to an increased bone turnover [40].
Nevertheless, serum PINP levels were similar in DISH and NDISH sub-
jects, which is in line with a recent study on 49 men that underwent
surgery for ossification of the posterior longitudinal ligament in cer-
vical spine (OPLL). The authors observed that PINP levels were not
significantly different in subjects with OPLL associated with DISH,
compared to those with cervical spondylosis [41].
Regarding to bone resorption markers, we have observed no dif-
ferences in serum CTX levels in subjects with or without DISH. In this
sense, serum levels of tartrate-resistant acid phosphatase 5b (TRAP-
5b), another biomarker of bone resorption, have been assessed in a
recent report, but no differences between DISH and NDISH subjects
were found [41]. With regard to the physiologic regulators of bone
turnover, DISH has been related to reduced DKK-1 levels, a protein
that inhibits osteogenesis induced by the Wnt/b-catenin pathway
[18,19].
This pattern of high values of markers of bone formation -ALP,
osteocalcin- as well as a decrease in DKK-1 levels would be consistent
with the anabolic phenotype of DISH [19]. Although the idea of defin-
ing DISH as a bone-forming disorder is intuitively attractive, our
study has shown that men with DISH had a higher level of ALP but
also a lower TBS. These results might support the bone production/n IDIVAL, de ClinicalKey.es por Elsevier en abril 15, 2020.
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[42] have recently suggested.
Our study presents the limitations inherent to its transversal
design, which allows investigating for association but not for direc-
tionality or causality. Another weakness is the lack of availability of
serum osteocalcin levels. Nevertheless, its main strength is that it
provides an analysis of the TBS values in DISH on a wide and well-
characterized prospective cohort of men over 50 years, not previ-
ously performed, to our knowledge.
Conclusion
In conclusion, TBS values were significantly lower in men diag-
nosed with DISH irrespective of age, BMI, and BMD. Our results might
suggest that in men >50 years, the process of ligamentous ossifica-
tion characteristic of DISH might be related to a worse trabecular
microstructure. Besides, serum ALP levels were higher in DISH indi-
viduals supporting the idea, together with the TBS results, that DISH
could be a bone production/loss continuum process and not a classic
bone-forming disorder. Future longitudinal studies are needed to
deep insight into the usefulness of TBS for assessing the risk of frac-
ture in these patients.
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